LOS ANGELES — Treating nicotine addiction with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) was associated with less weight gain compared with other smoking cessation treatments such as ...
ACHV's cytisinicline shows best-in-class efficacy and safety for smoking cessation, supported by strong clinical data and recent NDA submission. The target market is large, with millions seeking ...
Tuberculosis (TB) patients who smoke will recover far more quickly if they can quit—and help could come from their mobile ...
A new study debunks myths about vaping as a quitting aid, highlighting its link to prolonged nicotine addiction—here’s what smokers need to know. Study: Daily or Nondaily Vaping and Smoking Cessation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback